RU2011154171A - MARKERS OF CARDIOVASCULAR DISEASE - Google Patents
MARKERS OF CARDIOVASCULAR DISEASE Download PDFInfo
- Publication number
- RU2011154171A RU2011154171A RU2011154171/15A RU2011154171A RU2011154171A RU 2011154171 A RU2011154171 A RU 2011154171A RU 2011154171/15 A RU2011154171/15 A RU 2011154171/15A RU 2011154171 A RU2011154171 A RU 2011154171A RU 2011154171 A RU2011154171 A RU 2011154171A
- Authority
- RU
- Russia
- Prior art keywords
- seq
- age
- risk
- individual
- genetic
- Prior art date
Links
- 208000008787 Cardiovascular Disease Diseases 0.000 title claims 28
- 230000002068 genetic Effects 0.000 claims 36
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 18
- 230000000875 corresponding Effects 0.000 claims 16
- 230000004083 survival Effects 0.000 claims 10
- 229940107161 Cholesterol Drugs 0.000 claims 9
- 208000010125 Myocardial Infarction Diseases 0.000 claims 9
- 235000012000 cholesterol Nutrition 0.000 claims 9
- 230000035488 systolic blood pressure Effects 0.000 claims 9
- 206010002383 Angina pectoris Diseases 0.000 claims 8
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 8
- 238000002560 therapeutic procedure Methods 0.000 claims 8
- 230000000391 smoking Effects 0.000 claims 6
- 230000003321 amplification Effects 0.000 claims 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims 5
- 150000007523 nucleic acids Chemical group 0.000 claims 5
- 230000004044 response Effects 0.000 claims 5
- 206010010904 Convulsion Diseases 0.000 claims 4
- 206010039911 Seizure Diseases 0.000 claims 4
- 230000000271 cardiovascular Effects 0.000 claims 4
- 201000000522 chronic kidney disease Diseases 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 206010012601 Diabetes mellitus Diseases 0.000 claims 3
- 108010023302 HDL Cholesterol Proteins 0.000 claims 3
- 208000007474 Aortic Aneurysm Diseases 0.000 claims 2
- 206010007559 Cardiac failure congestive Diseases 0.000 claims 2
- 108060003412 GRP Proteins 0.000 claims 2
- 102000015779 HDL Lipoproteins Human genes 0.000 claims 2
- 208000006011 Stroke Diseases 0.000 claims 2
- 206010044390 Transient ischaemic attack Diseases 0.000 claims 2
- 230000036772 blood pressure Effects 0.000 claims 2
- 201000006233 congestive heart failure Diseases 0.000 claims 2
- 201000010875 transient cerebral ischemia Diseases 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 1
- 206010007554 Cardiac failure Diseases 0.000 claims 1
- 206010019280 Heart failure Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 108010028554 LDL Cholesterol Proteins 0.000 claims 1
- 238000008214 LDL Cholesterol Methods 0.000 claims 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 claims 1
- 108090001030 Lipoproteins Proteins 0.000 claims 1
- 102000004895 Lipoproteins Human genes 0.000 claims 1
- 210000000214 Mouth Anatomy 0.000 claims 1
- 206010038435 Renal failure Diseases 0.000 claims 1
- 210000003296 Saliva Anatomy 0.000 claims 1
- 210000002700 Urine Anatomy 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 238000004590 computer program Methods 0.000 claims 1
- 230000001809 detectable Effects 0.000 claims 1
- 230000035487 diastolic blood pressure Effects 0.000 claims 1
- 230000037213 diet Effects 0.000 claims 1
- 235000005911 diet Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 238000009396 hybridization Methods 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 229920000023 polynucleotide Polymers 0.000 claims 1
- 239000002157 polynucleotide Substances 0.000 claims 1
- 238000009117 preventive therapy Methods 0.000 claims 1
- 108091007521 restriction endonucleases Proteins 0.000 claims 1
- 238000007790 scraping Methods 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
Claims (20)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09162329.8 | 2009-06-09 | ||
EP09162329.8A EP2264183B1 (en) | 2009-06-09 | 2009-06-09 | Risk markers for cardiovascular disease |
PCT/EP2010/058064 WO2010142713A1 (en) | 2009-06-09 | 2010-06-09 | Risk markers for cardiovascular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011154171A true RU2011154171A (en) | 2013-07-20 |
RU2524659C2 RU2524659C2 (en) | 2014-07-27 |
Family
ID=41061079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011154171/15A RU2524659C2 (en) | 2009-06-09 | 2010-06-09 | Markers of risk of cardiovascular disease |
Country Status (14)
Country | Link |
---|---|
US (1) | US9957565B2 (en) |
EP (2) | EP2264183B1 (en) |
AR (1) | AR077026A1 (en) |
AU (1) | AU2010257482B2 (en) |
BR (1) | BRPI1013082A2 (en) |
CA (1) | CA2764693C (en) |
CL (1) | CL2011003129A1 (en) |
ES (2) | ES2623633T3 (en) |
MX (1) | MX2011013243A (en) |
PE (1) | PE20121029A1 (en) |
PT (2) | PT2264183T (en) |
RU (1) | RU2524659C2 (en) |
UY (1) | UY32698A (en) |
WO (1) | WO2010142713A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2656148C2 (en) * | 2013-08-30 | 2018-05-31 | Хендиаг.Эксе, С.Л. | Risk markers for cardiovascular diseases in patients with chronic kidney disease |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10359425B2 (en) | 2008-09-09 | 2019-07-23 | Somalogic, Inc. | Lung cancer biomarkers and uses thereof |
AU2011274422B2 (en) | 2010-07-09 | 2016-02-11 | Somalogic Operating Co., Inc. | Lung cancer biomarkers and uses thereof |
WO2012021795A2 (en) | 2010-08-13 | 2012-02-16 | Somalogic, Inc. | Pancreatic cancer biomarkers and uses thereof |
EP2554679B1 (en) * | 2011-08-05 | 2016-03-02 | Gendiag.exe, S.L. | Genetic markers for cardiovascular disease risk assessment |
SG11201400904SA (en) * | 2011-09-30 | 2014-04-28 | Somalogic Inc | Cardiovascular risk event prediction and uses thereof |
RU2547575C1 (en) * | 2014-02-06 | 2015-04-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославская государственная медицинская академия" Министерства здравоохранения Российской Федерации | Method for predicting clinical course of chronic cardiac failure |
RU2602451C1 (en) * | 2015-08-28 | 2016-11-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Красноярский государственный медицинский университет имени профессора В.Ф. Войно-Ясенецкого" Министерства здравоохранения Российской Федерации | Diagnostic technique for genetic predisposition to ischemic stroke development in patients with atrial fibrillation |
EP3360067A4 (en) * | 2015-10-07 | 2019-06-12 | The Board Of Trustees Of The University Of the Leland Stanford Junior University | Techniques for determining whether an individual is included in ensemble genomic data |
RU2624859C1 (en) * | 2016-06-15 | 2017-07-07 | Общество с ограниченной ответственностью "Меднорд-Техника" (ООО "Меднорд-Техника") | Method for estimation of increased risk of phlebothromboses formation in patients with ischemic heart disease |
CN106250524A (en) * | 2016-08-04 | 2016-12-21 | 浪潮软件集团有限公司 | Organization name extraction method and device based on semantic information |
US10451544B2 (en) | 2016-10-11 | 2019-10-22 | Genotox Laboratories | Methods of characterizing a urine sample |
WO2019191010A1 (en) * | 2018-03-27 | 2019-10-03 | Aardvark Therapeutics Inc. | Personalized treatment method for congestive heart failure |
US11308325B2 (en) * | 2018-10-16 | 2022-04-19 | Duke University | Systems and methods for predicting real-time behavioral risks using everyday images |
CN110229882A (en) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | One kind mthfr gene molecular labeling relevant to cardiovascular disease and its application |
CN110229881A (en) * | 2019-07-03 | 2019-09-13 | 贵州省临床检验中心 | One kind SNP marker relevant to adult cardiovascular disease and its application |
CN112210598A (en) * | 2019-07-11 | 2021-01-12 | 合肥中科普瑞昇生物医药科技有限公司 | Primer group and kit for detecting polymorphism of gene related to metabolism of hyperglycemia drug and application of primer group and kit |
CN110607360A (en) * | 2019-09-19 | 2019-12-24 | 华中科技大学同济医学院附属同济医院 | Primer group and kit for assessing chronic heart failure prognosis and method for assessing chronic heart failure prognosis |
WO2021207587A1 (en) * | 2020-04-11 | 2021-10-14 | Geneticure Inc. | Genetic method for diagnosis and treatment of pre and post coronavirus infections |
US11610645B2 (en) * | 2020-04-30 | 2023-03-21 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11967430B2 (en) | 2020-04-30 | 2024-04-23 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11574738B2 (en) | 2020-04-30 | 2023-02-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11978532B2 (en) | 2020-04-30 | 2024-05-07 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
US11482302B2 (en) | 2020-04-30 | 2022-10-25 | Optum Services (Ireland) Limited | Cross-variant polygenic predictive data analysis |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US723961A (en) | 1902-10-01 | 1903-03-31 | Nelson W Clark | Lady's belt, collar, or the like. |
US4883750A (en) | 1984-12-13 | 1989-11-28 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4800159A (en) | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
US5004565A (en) | 1986-07-17 | 1991-04-02 | The Board Of Governors Of Wayne State University | Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes |
US5856522A (en) | 1995-05-04 | 1999-01-05 | Tropix, Inc. | Method of using synthesis of 1,2-dioxetanes and kits therefore |
US5994073A (en) | 1990-08-30 | 1999-11-30 | Tropix, Inc. | Enhancement of chemiluminescent assays |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
AU8126694A (en) | 1993-10-26 | 1995-05-22 | Affymax Technologies N.V. | Arrays of nucleic acid probes on biological chips |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5773628A (en) | 1994-11-14 | 1998-06-30 | Tropix, Inc. | 1,2-dioxetane compounds with haloalkoxy groups, methods preparation and use |
US5591591A (en) | 1995-02-09 | 1997-01-07 | Tropix, Inc. | Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore |
US5589136A (en) | 1995-06-20 | 1996-12-31 | Regents Of The University Of California | Silicon-based sleeve devices for chemical reactions |
US5679803A (en) | 1995-10-25 | 1997-10-21 | Tropix, Inc. | 1,2 chemiluminescent dioxetanes of improved performance |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US5800999A (en) | 1996-12-16 | 1998-09-01 | Tropix, Inc. | Dioxetane-precursor-labeled probes and detection assays employing the same |
CN1105914C (en) | 1997-04-25 | 2003-04-16 | 卡钳技术有限公司 | Microfluidic devices incorporating improved channel geometries |
US6159693A (en) | 1998-03-13 | 2000-12-12 | Promega Corporation | Nucleic acid detection |
WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
US20070015170A1 (en) * | 2005-07-12 | 2007-01-18 | Oy Jurilab Ltd | Method and kit for detecting a risk of coronary heart disease |
RU2322193C1 (en) | 2006-12-04 | 2008-04-20 | Федеральное государственное учреждение "Учебно-научный медицинский центр" Управления делами Президента Российской Федерации | Method for evaluating genetic cardiovascular disease risk in sportsmen |
NZ579445A (en) * | 2007-02-21 | 2012-02-24 | Decode Genetics Ehf | Genetic susceptibility variants associated with cardiovascular disease |
US7883851B2 (en) | 2007-05-02 | 2011-02-08 | Board Of Regents, The University Of Texas System | Common allele on chromosome 9 associated with coronary heart disease |
-
2009
- 2009-06-09 EP EP09162329.8A patent/EP2264183B1/en not_active Not-in-force
- 2009-06-09 ES ES09162329.8T patent/ES2623633T3/en active Active
- 2009-06-09 PT PT91623298T patent/PT2264183T/en unknown
-
2010
- 2010-06-09 PE PE2011002069A patent/PE20121029A1/en not_active Application Discontinuation
- 2010-06-09 AU AU2010257482A patent/AU2010257482B2/en not_active Ceased
- 2010-06-09 AR ARP100102016A patent/AR077026A1/en unknown
- 2010-06-09 MX MX2011013243A patent/MX2011013243A/en active IP Right Grant
- 2010-06-09 WO PCT/EP2010/058064 patent/WO2010142713A1/en active Application Filing
- 2010-06-09 BR BRPI1013082A patent/BRPI1013082A2/en not_active IP Right Cessation
- 2010-06-09 ES ES10725412.0T patent/ES2627446T3/en active Active
- 2010-06-09 CA CA2764693A patent/CA2764693C/en active Active
- 2010-06-09 EP EP10725412.0A patent/EP2440674B1/en not_active Not-in-force
- 2010-06-09 RU RU2011154171/15A patent/RU2524659C2/en not_active IP Right Cessation
- 2010-06-09 PT PT107254120T patent/PT2440674T/en unknown
- 2010-06-09 US US13/377,216 patent/US9957565B2/en active Active
- 2010-06-09 UY UY0001032698A patent/UY32698A/en unknown
-
2011
- 2011-12-09 CL CL2011003129A patent/CL2011003129A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2656148C2 (en) * | 2013-08-30 | 2018-05-31 | Хендиаг.Эксе, С.Л. | Risk markers for cardiovascular diseases in patients with chronic kidney disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011154171A (en) | MARKERS OF CARDIOVASCULAR DISEASE | |
CA2764693C (en) | Risk markers for cardiovascular disease | |
CN115917001A (en) | Method for detecting donor-derived free DNA | |
KR101545258B1 (en) | Biomarker for predicting of sensitivity to exercise | |
US20140094381A1 (en) | Predictive Biomarkers for Response to Exercise | |
Luk et al. | Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes—an 8-year prospective cohort analysis of 1327 Chinese patients | |
WO2013020870A4 (en) | Cardiovascular disease | |
KR101722107B1 (en) | Diabetes diagnosis and prediction methods using single nucleotide polymorphism based-Genetic Risk Score in Korean | |
KR101536213B1 (en) | SNP markers for abdominal obesity and use thereof | |
WO2012094366A1 (en) | Circulating mirnas as biomarkers for coronary artery disease | |
KR101532308B1 (en) | SNP markers for abdominal obesity and use thereof | |
US20230383349A1 (en) | Methods of assessing risk of developing a disease | |
CN104404044B (en) | Detection method and its application with the susceptible relevant ANRIL gene extrons sub-district mononucleotide polymorphic site of myocardial infarction | |
JP6810834B2 (en) | How to Predict Response to Continuous Positive Pressure Respiratory Therapy | |
CN105200131A (en) | Kit based on 14 SNP loci for evaluating peripheral arterial disease prevalence risk | |
Gupta et al. | β-T594M epithelial sodium channel gene polymorphism and essential hypertension in individuals of Indo-Aryan ancestry in Northern India | |
KR20210081188A (en) | Biomarker for predicting skin moisturizing risk and use thereof | |
KR101543774B1 (en) | SNP markers for abdominal obesity and use thereof | |
WO2022247903A1 (en) | Polygenic risk score for coronary heart disease, construction method therefor, and application thereof in combination with clinical risk assessment | |
KR101673162B1 (en) | Biomarker for predicting of sensitivity to exercise | |
KR101673148B1 (en) | Biomarker for predicting of sensitivity to exercise | |
KR101673156B1 (en) | Biomarker for predicting of sensitivity to exercise | |
JP2017006074A (en) | Peripheral arterial disease inspection method and inspection reagent | |
Marchiori et al. | Identification of epigenetic biomarkers associated with the development of diabetic kidney disease in individuals with type 2 diabetes: a nested cohort study | |
WO2019234045A1 (en) | Method for evaluating risk of cardiovascular disease |